|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,507.00 GBX | -0.36% |
|
-1.77% | +5.18% |
| 12:32pm | Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say | RE |
| 10:05am | European health regulator chief says EU needs more say in securing access to new drugs | RE |
MarketScreener Editorial Features
Search
No results for this search
Filters
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition





























